With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...

Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are ...

PCI Pharma Services, a CDMO, and the biotech ChiRhoClin inked a collaboration deal to address the potential shortage of a ...

Unexo Life Sciences, an Indian drugmaker that manufactures a medicated patch for pain relief, has been hit with a ...

As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety ...

Although AstraZeneca, Daiichi Sankyo and England’s drug cost watchdog have spent months trying to hash out a fair price for ...

As BeiGene works to change its corporate identity and grow the reach of its cancer offerings around the globe, the company ...

After a labeling mix-up prompted a recall of a popular panic disorder drug this summer, Endo’s U.S. subsidiary is widening the scope of its product pull. | Endo USA is expanding its previous recall of ...

On Tuesday, company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating ...

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

Robert F. Kennedy Jr.'s nomination as the Trump administration's Department of Health and Human Services (HHS) secretary has ...

Neurology patient groups have chided the pharma industry for investing too little into treating disorders of the nervous ...